In 2023, Shanghai Henlius Biotech completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).
However, Shanghai Henlius Biotech has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2023 | 2022 | 2021 | 2020 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Shanghai Henlius Biotech’s data sources below and access millions more through our Disclosure Search.
In 2023, the total operational greenhouse gas (GHG) emissions of Shanghai Henlius Biotech amounted to 21,973 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2022, the total operational greenhouse gas (GHG) emissions of Shanghai Henlius Biotech increased by 3.82%, suggesting that the company faced challenges in reducing its emissions from its core operations. a
In 2023, the total Scope 1 emissions of Shanghai Henlius Biotech were 6,908.63 metric tons of CO₂ equivalent (tCO₂e). a
Since 2020, Shanghai Henlius Biotech's Scope 1 emissions have increased by 24.82%, reflecting a rising long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2022), Shanghai Henlius Biotech's Scope 1 emissions increased by 6.61%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a
In 2023, Shanghai Henlius Biotech reported Scope 2 greenhouse gas (GHG) emissions of 15,064.37 tCO₂e without specifying the calculation method. a
Since 2020, Shanghai Henlius Biotech's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have remained relatively stable, indicating that Shanghai Henlius Biotech 's emissions have plateaued with no significant change in its energy consumption footprint. a b
Compared to the previous year (2022), Shanghai Henlius Biotech's Scope 2 emissions (Unspecified Calculation Method) have remained relatively stable, indicating that Shanghai Henlius Biotech 's emissions have plateaued with no significant change in its energy consumption footprint. a
In 2023, Shanghai Henlius Biotech reported its Scope 2 emissions using an unspecified methodology. a
In 2023, Shanghai Henlius Biotech reported Scope 1 greenhouse gas (GHG) emissions of 6,908.63 tCO₂e and total revenues of USD 830 millions. This translates into an emissions intensity of 8.32 tCO₂e per millions USD. a
In 2023, Shanghai Henlius Biotech reported a Scope 1 emissions intensity of 8.32 tCO₂e per millions USD. Compared to the peer group median of 9.75 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
In 2023, Shanghai Henlius Biotech ranked 11 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Shanghai Henlius Biotech is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a